| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +38.0% |
| Cost of Revenue | $399.6M | +45.6% |
| R&D Expense | $90.7M | +22.8% |
| SG&A Expense | $204.6M | -0.4% |
| Operating Income | -$67.9M | +59.5% |
| Interest Expense | $7.1M | -34.7% |
| Pre-tax Income | -$74.9M | +59.8% |
| Income Tax | -$5.2M | -599.1% |
| Net Income | -$69.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $366.2M | +178.0% |
| Accounts Receivable | $235.2M | +38.3% |
| Current Assets | $616.5M | +99.0% |
| Total Assets | $1.11B | +101.8% |
| Current Liabilities | $199.3M | +13.0% |
| Long-term Debt | $196.3M | +6.6% |
| Total Liabilities | $434.6M | +17.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $133.9M | +47.9% |
| Capital Expenditures | $25.7M | +25.6% |
| Investing Cash Flow | -$97.6M | -80.0% |
| Financing Cash Flow | $197.9M | +871.6% |
| Free Cash Flow | $108.1M | +54.4% |
| +62.8% |
| EPS (Basic) | -$0.38 | +68.3% |
| EPS (Diluted) | -$0.38 | +68.3% |
| Stockholders' Equity |
| $676.8M |
| +274.9% |